Source:http://linkedlifedata.com/resource/pubmed/id/21176738
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2010-12-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0946-1965
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
81-2
|
pubmed:meshHeading |
pubmed-meshheading:21176738-Antimetabolites, Antineoplastic,
pubmed-meshheading:21176738-Cell Line, Tumor,
pubmed-meshheading:21176738-Cell Survival,
pubmed-meshheading:21176738-Colonic Neoplasms,
pubmed-meshheading:21176738-Drug Resistance, Neoplasm,
pubmed-meshheading:21176738-Fluorouracil,
pubmed-meshheading:21176738-Humans
|
pubmed:year |
2011
|
pubmed:articleTitle |
Cross-resistance of 5-fluorouracil-resistant colon carcinoma in vitro.
|
pubmed:affiliation |
Department of Medicine I, Medical University of Vienna, Vienna, Austria.
|
pubmed:publicationType |
Journal Article
|